News

Latest news from the biobanking and life sciences industry. Publish Your News Release Here

Circuit Clinical™ Partners With CUBRC Applying Machine Learning To Predict Therapy Response

Circuit Clinical™, one of the USA's largest integrated research organizations dedicated to empowering patients to choose clinical research as a care option, has announced a ground-breaking strategic partnership with CUBRC (Calspan-University at Buffalo Research Center), a company...
video

AMRA Medical Publish Study Predicting Disease With UK Biobank Data

Scientists from AMRA have conducted a study, published in Obesity journal, predicting the occurrence of disease in individual patients based on real-world evidence from the UK Biobank. Individualized data can be used to create virtual control groups...
video

Basic Research And Treatment Strategies For Hereditary Aggrecan Deficiency Awarded

Recently, an international team of researchers received the 2019 Human Growth Award at the Pediatric Endocrine Society's Annual Meeting for their abstract, entitled "Clinical Characterization and Trial of Growth Hormone in Patients with Aggrecan Deficiency: 6 Month Data," and presented this...

University of Helsinki Research Team Finds That Antihistamine Acts Against Glioblastoma Cells

Researchers from the University of Helsinki have discovered that the cells of glioblastoma, a lethal brain cancer, often depend on fatty acid-binding protein 3 (FABP3), also known as MDGI, for survival. Informed consent was obtained from all...

ExCellThera And NYBC’s Comprehensive Cell Solutions Enter Manufacturing Agreement

ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, has announced that it has entered into a manufacturing and collaboration agreement with Comprehensive Cell Solutions (CCS), a division...

Predictive Laboratories Hits The 200 Participant Milestone In Their Chronic Pain Study

Predictive Technology Group, Inc., a leader in the use of data analytics for disease identification and subsequent precision therapeutic intervention, has announced that its wholly owned subsidiary Predictive Laboratories has reached an enrollment milestone of 200 participants in its...

RenalytixAI To Validate KidneyIntelX™ In Collaboration With University Medical Center Groningen

Renalytix AI plc, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, has announced a collaboration with University Medical Center Groningen (UMCG), Netherlands, to evaluate KidneyIntelX™ across over 3,500 patients with Type II Diabetes. The study will assess how effectively...

Patent-Pending Biosensor And Method For Detecting Early Stage Alzheimer’s Developed

Scientists from Ruhr-Universität Bochum (RUB), in Germany have developed a test using two biomarkers that can detect Alzheimer’s (AD) at an early stage. The method was developed from samples banked from 61 disease control patients and 39...

Canopy Biosciences Adds Biobanking And Multiplex Cytometry Technology By Acquiring Zellkraftwerk

Canopy Biosciences™, LLC, a leading provider of gene editing and gene expression products and services, has acquired Zellkraftwerk GmbH, a leader in multiplex cytometry. Leveraging its innovative ChipCytometry platform, Zellkraftwerk offers complete workflow solutions—including both products and research services—for high-content cytometry...

Opportunity To Develop Nerve Agent Antidote At Scale From Human Umbilical Cord Cells

Aurora BioSolutions Inc. and Tissue Regeneration Therapeutics Inc. (TRT) have announced that they have discovered that human umbilical cord cells are a sustainable source of human butyrylcholinesterase (HuBChE), a bioscavenger that neutralizes organophosphate nerve toxins. Furthermore, the...

🔉 Stay Connected

955FollowersFollow

🔥 Most Popular



Featured Vendors
X